ONC-113B

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameONC-113B
Drug Alias NameONC-113BONC1-0013BONK1-0013BONK1-0013VONC1-13B +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor antagonists
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlla Chem
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvionco Llc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms, Castration-Resistant

Other Information

ATC CodeN/A
Related LinksN/A